Interview with Professor Sir John Bell, Chair, Office for the…
It are exciting times for the UK, with the public healthcare system undergoing so many changes. The Office of Life Sciences (OLS) and the Therapeutic…
Interview with Richard Blackburn, Managing Director, Pfizer UK
As part of a panel discussion with Claudia Hammond of the BBC last year, you commented on the fairly poor relationship between the NHS and industry,…
Interview with Warwick Smith, Director, British Generic…
Together with Germany, the UK the highest generic penetration rate in Europe. Since you have been with the association since 1995 and obviously saw…
Interview with Stephen Whitehead, Chief Executive Officer,…
What are the priorities on your agenda as the new head of ABPI considering the successes and difficulties the association has experienced in the past?…
Interview with Nigel Gaymond, Chief Executive, BioIndustry…
The UK has got around half of the public biotech companies and 21% of all entrepreneurial bioscience companies in Europe. From your perspective, can…
Interview with Mark Jones, Marketing Company President,…
AstraZeneca reported decrease in its global revenue for the first half of 2011 mostly due to adverse market conditions in the US. In this context, how…
Interview with Sheila Kelly, Chief Executive, Proprietary…
Thank you for having us today! You have been chief executive of the Association since 1990 and obviously observed the evolution of the OTC market from…
Interview with Simon Jose, General Manager UK, GlaxoSmithKline
Given the heated debate over NHS reform and the new revised bill proposed by the government, what are you current priorities as President of the ABPI…